Diagnostic utility of single-user peroral cholangioscopy in sclerosing cholangitis

Scandinavian Journal of Gastroenterology

Volumn 49, Issue 10, 2014, Pages 1237-1244

  Kalaitzakis, Evangelos ^a   Sturgess, Richard ^b   Kaltsidis, Harry ^c   Oppong, Kofi ^d   Lekharaju, Venkata ^b   Bergenzaun, Per ^a   Vlavianos, Panagiotis ^c   Sharma, Hemant ^e   Westaby, David ^c   Webster, George J ^e  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^d FREEMAN HOSPITAL   (United Kingdom)

^e UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Cholangiocarcinoma; Cholangioscopy; Endoscopic retrograde cholangiopancreatography; IgG4 related sclerosing cholangitis; Primary sclerosing cholangitis

Indexed keywords

ADULT; ARTICLE; BILIARY TRACT ENDOSCOPY; CANCER DIAGNOSIS; CANNULATION; CHOLECYSTITIS; CHOLESTASIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN G4 RELATED DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIMARY SCLEROSING CHOLANGITIS; RETROSPECTIVE STUDY; SCLEROSING CHOLANGITIS; SENSITIVITY AND SPECIFICITY; SINGLE OPERATOR PERORAL CHOLANGIOSCOPY; ADVERSE EFFECTS; AGED; BILE DUCT; BILE DUCT NEOPLASMS; BIOPSY; CASE CONTROL STUDY; CATHETERIZATION; CHOLANGITIS, SCLEROSING; COMPLICATION; CONSTRICTION, PATHOLOGIC; DIGESTIVE TRACT ENDOSCOPY; LABORATORY DIAGNOSIS; MIDDLE AGED; MOUTH; PATHOLOGY; PROCEDURES;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS; BIOPSY; CASE-CONTROL STUDIES; CATHETERIZATION; CHOLANGITIS, SCLEROSING; CONSTRICTION, PATHOLOGIC; ENDOSCOPY, DIGESTIVE SYSTEM; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 84907235578     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2014.936032     Document Type: Article

References (28)

1. Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010;51:660-78.
2. Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ, et al. Immunoglobulin G4-Associated cholangitis: Clinical profile and response to therapy. Gastroenterology 2008;134:706-15.
3. Kalaitzakis E, Webster GJ. Review article: Autoimmune pancreatitis-management of an emerging disease. Aliment Pharmacol Ther 2011;33:291-303.
4. Trikudanathan G, Navaneethan U, Njei B, Vargo JJ, Parsi MA. Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: A systematic review and meta-Analysis. Gastrointest Endosc 2014;79:783-9.
5. Fukuda Y, Tsuyuguchi T, Sakai Y, Tsuchiya S, Saisyo H. Diagnostic utility of peroral cholangioscopy for various bile-duct lesions. Gastrointest Endosc 2005;62:374-82.
6. Shah RJ, Langer DA, Antillon MR, Chen YK. Cholangioscopy and cholangioscopic forceps biopsy in patients with indeterminate pancreaticobiliary pathology. Clin Gastroenterol Hepatol 2006;4:219-25.
7. Draganov PV, Lin T, Chauhan S, Wagh MS, Hou W, Forsmark CE. Prospective evaluation of the clinical utility of ERCP-guided cholangiopancreatoscopy with a new direct visualization system. Gastrointest Endosc 2011;73:971-9.
8. Ramchandani M, Reddy DN, Gupta R, Lakhtakia S, Tandan M, Darisetty S, et al. Role of single-operator peroral cholangioscopy in the diagnosis of indeterminate biliary lesions: A single-center, prospective study. Gastrointest Endosc 2011;74:511-19.
9. ChenYK,ParsiMA,BinmoellerKF,HawesRH, PleskowDK, Slivka A, et al. Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with video). Gastrointest Endosc 2011;74:805-14.
10. Kalaitzakis E, Webster GJ, Oppong KW, Kallis Y, Vlavianos P, Huggett M, et al. Diagnostic and therapeutic utility of single-operator peroral cholangioscopy for indeterminate biliary lesions and bile duct stones. Eur J Gastroenterol Hepatol 2012;24:656-64.
11. Tischendorf JJ, Kruger M, Trautwein C, Duckstein N, Schneider A, Manns MP, et al. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Endoscopy 2006;38:665-9.
12. Awadallah NS, Chen YK, Piraka C, Antillon MR, Shah RJ. Is there a role for cholangioscopy in patients with primary sclerosing cholangitis? Am J Gastroenterol 2006; 101:284-91.
13. Itoi T, Kamisawa T, Igarashi Y, Kawakami H, Yasuda I, Itokawa F, et al. The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis. J Gastroenterol 2013;48:504-14.
14. Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, MeyersWC, et al. Endoscopic sphincterotomy complications and their management: An attempt at consensus. Gastrointest Endosc 1991;37:383-93.
15. Darwish Murad S, Kim WR, Harnois DM, Douglas DD, Burton J, Kulik LM, et al. Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology 2012; 143:88-98 e3.quiz e14.
16. Erdogan D, Kloek JJ, ten Kate FJ, Rauws EA, Busch OR, Gouma DJ, et al. Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures. Br J Surg 2008;95:727-34.
17. Lytras D, Kalaitzakis E, Webster GJM, Imber CJ, Amin Z, Rodriguez-Justo M, et al. Cholangiocarcinoma or IgG4-Associated cholangitis: How feasible it is to avoid unnecessary surgical interventions? Ann Surg 2012;256(6):1059-67.
18. Kalaitzakis E, Levy M, Kamisawa T, Johnson GJ, Baron TH, TopazianMD, et al. Endoscopic retrograde cholangiography does not reliably distinguish IgG4-Associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma. Clin Gastroenterol Hepatol 2011;9:800-3 e2.
19. Ohara H, Okazaki K, Tsubouchi H, Inui K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci 2012;19:536-42.
20. Azeem N, Gostout CJ, Knipschield M, Baron TH. Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP. Gastrointest Endosc 2014;79:773-779.e2.
21. Heif M, Yen RD, Shah RJ. ERCP with probe-based confocal laser endomicroscopy for the evaluation of dominant biliary stenoses in primary sclerosing cholangitis patients. Dig Dis Sci 2013;58:2068-74.
22. Kawakami H, Zen Y, Kuwatani M, Eto K, Haba S, Yamato H, et al. IgG4-related sclerosing cholangitis and autoimmune pancreatitis: Histological assessment of biopsies from Vater's ampulla and the bile duct. J Gastroenterol Hepatol 2010;25:1648-55.
23. Kimura Y, Harada K, Nakanuma Y. Pathologic significance of immunoglobulin G4-positive plasma cells in extrahepatic cholangiocarcinoma. Hum Pathol 2012;43:2149-56.
24. Sethi A, Shah NL, Pleskow D, Edmundowitz SA, Sejpal DV, Gress F, et al. Interobserver agreement for single operator choledochoscopy imaging reading: What are we looking at? Dig Liver Dis 2014;46:518-22.
25. Sethi A, Chen YK, Austin GL, Brown WR, Brauer BC, Fukami NN, et al. ERCP with cholangiopancreatoscopy may be associated with higher rates of complications than ERCP alone: A single-center experience. Gastrointest Endosc 2011; 73:251-6.
26. Kipp BR, Stadheim LM, Halling SA, Pochron NL, Harmsen S, Nagorney DM, et al. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol 2004;99:1675-81.
27. Levy MJ, Baron TH, Clayton AC, Enders FB, Gostout CJ, Halling KC, et al. Prospective evaluation of advanced molecular markers and imaging techniques in patients with indeterminate bile duct strictures. Am J Gastroenterol 2008;103: 1263-73.
28. Bangarulingam SY, Bjornsson E, Enders F, Barr Fritcher EG, Gores G, Halling KC, et al. Long-Term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis. Hepatology 2010;51: 174-80.